DEA's Own Pharmacologist Undercuts Marijuana Rescheduling Order
One witness may ultimately define the entire DEA marijuana rescheduling proceeding-not because she opposed marijuana legalization, but because she authored the Drug Enforcement Administration's own scientific review. Dr. Luli Akinfiresoye, a pharmacologist in DEA's Drug and Chemical Evaluation Section and author of the agency's 2024 Scientific Data Review, testified under subpoena during the marijuana rescheduling hearing. Her testimony...
Read more








